• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»Cross Country Healthcare

Why Knox Lane is taking Cross Country Healthcare private in a $437m all-cash deal

By Pallavi Madhiraju on May 7, 2026   Pharma & Biotech  

Why Knox Lane is taking Cross Country Healthcare private in a $437m all-cash deal

Healthcare staffing is still under pressure. Knox Lane’s $437m Cross Country Healthcare deal turns that reset into a private equity wager.

Recent Posts

  • Why Sensus Healthcare’s SkinCure resolution matters for superficial radiotherapy growth
  • Why Encompass Health is betting on a fast-growing Texas suburb before rivals crowd in
  • What Saban Community Clinic’s Crenshaw project reveals about urban healthcare deserts
  • Cryo-Cell avoided a delisting scare for now, but investors still face a 2027 countdown
  • Ensoma’s EN-374 safety data open a new test for in vivo HSC engineering
  • Why bioAffinity’s CyPath Lung growth still leaves investors facing a hard cash question
  • Can Kanvas Biosciences turn microbiome replacement into a maternal health intervention?
  • Could Actio’s KCNT1 epilepsy drug become an ultra-rare disease test case for the FDA?
  • Lumenis strengthens FoLix, ULTRApulse Alpha and Stellar M22 case with ASLMS data
  • How Zifo’s AI authoring platform could reshape clinical and CMC documentation
  • INOVIO’s ASCO and ASGCT updates may sharpen scrutiny of its DNA medicine strategy
  • Pharma has a Hispanic engagement problem. Relevant+ thinks Healthy Vibras can fix it
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes